Considering that FABP3 is a highly sensitive predictor of MI, especially in patients with MS, which is strongly linked to psoriasis, we assumed that this protein could serve as a marker of heart failure in patients with this dermatosis. This evidence concerns the gene FABP3 and myeloid sarcoma.